Processa Pharmaceuticals, Inc. Gross Profit

• Processa Pharmaceuticals, Inc. showed an increase of +140.2% in Gross Profit from 2015 to 2016.
• This data is from Processa Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on September 25, 2017.
• XBRL data for this metric is available from 2012 to 2016 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2012: $15.1 thousand | Q1 2013: $7.1 thousand | Q2 2013: $35.8 thousand | Q3 2013: $45.5 thousand | Q1 2014: $11.2 thousand | Q2 2014: $42.6 thousand | Q3 2014: $27.3 thousand | Q1 2015: $12.8 thousand | Q2 2015: $9.0 thousand | Q3 2015: $15.5 thousand | Q1 2016: $5.0 thousand.
• Over the full 5 years of available data (2012 to 2016), Processa Pharmaceuticals, Inc.'s Gross Profit has declined by 91.5%.
• Historical annual values: Fiscal year 2016: $5.0 thousand | Fiscal year 2015: -$12.5 thousand | Fiscal year 2014: $40.4 thousand | Fiscal year 2013: $124.5 thousand | Fiscal year 2012: $58.9 thousand.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026